scholarly article | Q13442814 |
P2093 | author name string | Jun Zhang | |
Ting Wu | |||
Xue-Feng Zhang | |||
Feng-Cai Zhu | |||
Ning-Shao Xia | |||
Shou-Jie Huang | |||
Zhong-Ze Wang | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | human pregnancy | Q11995 |
hepatitis E | Q326643 | ||
pregnant person | Q104720811 | ||
P304 | page(s) | 2038 | |
P577 | publication date | 2012-06-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis | |
P478 | volume | 55 |
Q37197088 | A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions |
Q33747037 | A systematic review of the epidemiology of hepatitis E virus in Africa |
Q28077096 | Adult immunization-Need of the hour |
Q36973372 | Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy. |
Q30251843 | Case-fatality risk of pregnant women with acute viral hepatitis type E: a systematic review and meta-analysis |
Q35887653 | Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment |
Q35683323 | Enhanced humoral response in pregnant mice immunized with liposome encapsulated recombinant neutralizing epitope protein of Hepatitis- E virus |
Q37573028 | Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection |
Q92376567 | Hepatitis E Virus Drug Development |
Q27002938 | Hepatitis E in Germany--an under-reported infectious disease |
Q54334450 | Hepatitis E vaccine development: a 14 year odyssey. |
Q41089524 | Hepatitis E vaccine immunization for rabbits to prevent animal HEV infection and zoonotic transmission |
Q26751267 | Hepatitis E virus as an emerging zoonotic pathogen |
Q96299192 | Hepatitis E virus infection during pregnancy |
Q38014371 | Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity |
Q26852254 | Hepatitis E, a vaccine-preventable cause of maternal deaths |
Q38379216 | Hepatitis E: A disease of reemerging importance |
Q55038767 | Hepatitis E: Still Waters Run Deep. |
Q54254955 | Hepatitis E: Update on Prevention and Control. |
Q38582155 | Hepatitis E: an emerging global disease - from discovery towards control and cure |
Q30234939 | Hepatitis E: the current state of play. |
Q35072039 | Hepatitis e vaccine to prevent morbidity and mortality during epidemics |
Q37544940 | Host immune status and response to hepatitis E virus infection. |
Q47561286 | Immunity against hepatitis E virus infection: Implications for therapy and vaccine development |
Q52659699 | Immunization against Hepatitis E. |
Q39222506 | Investigation of hepatitis E outbreak among refugees - Upper Nile, South Sudan, 2012-2013. |
Q47556196 | Knowledge gaps and research priorities in the prevention and control of hepatitis E virus infection. |
Q27013018 | Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins |
Q37534616 | Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine |
Q35905989 | Maternal-Fetal Hepatitis E Transmission: Is It Underestimated? |
Q40507392 | Prophylactic Hepatitis E Vaccine |
Q56909142 | Reactive and pre-emptive vaccination strategies to control hepatitis E infection in emergency and refugee settings: A modelling study |
Q38268414 | Risk factors for hepatitis E virus infection and disease. |
Q42212470 | Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®). |
Q92829439 | Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China |
Q91714520 | The Clinical Perspective on Hepatitis E |
Q34464464 | The development of a recombinant hepatitis E vaccine HEV 239. |
Q37130825 | Viral hepatitis vaccination during pregnancy |
Search more.